article thumbnail

[DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health

OurCrowd

The post [DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health appeared first on OurCrowd. NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp. Read more here.

health 36
article thumbnail

[DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System

OurCrowd

Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. The post [DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System appeared first on OurCrowd.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

[DarioHealth in Yahoo Finance] DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

OurCrowd

(Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.

article thumbnail

[DarioHealth in Yahoo Finance] DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

(Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. Food and Drug. Read more here.

article thumbnail

[DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions

OurCrowd

(Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. Eastern Time. Read more here.

article thumbnail

MedRhythms Uses the Universal Language of Music to Bring Hope, Healing to Mobility Impaired Patients

Angel Capital Association

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

article thumbnail

NJEDA Names Inaugural New Jersey Innovation Fellows Cohort

American Entrepreneurship

The curriculum will provide training in subjects such as managerial finance, accounting, and financial statement preparations; human resources development and management; business model design; marketing and customer development; and more. The company will focus on building its digital proprietary platform and easy-to-use digital application.